Development and internal validation of an immune-based prognostic modeling of early-onset colorectal cancer <i>via</i> machine learning

This two-factor model offers moderate accuracy for personalized EOCRC risk stratification, highlighting systemic NK cell dysfunction as a potential immunotherapy target. External validation is warranted.